HSCT Graft vs Host Disease (GVHD)
There is a knowledge deficit in the pathophysiology, morbidity, mortality, and treatment options associated with GVHD. Gaps in knowledge can lead to slower recognition, treatment, and advocacy for this patient population. Since immunosuppression is currently the mainstay of treatment these patients are at increased risk for infection and other secondary complications from acute and chronic GVH.
Release Date:
October 2021
Expiration Date:
October 2024
Estimated Duration of Course:
1 hour
This offering carries 1.00 ANCC nursing contact hour.
Target Audience
The target audience is RNs, APPs, and those providing direct clinical care to this patient population.
Learning Objectives
- Describe the pathophysiology and diagnosis of patients with acute and chronic GVH.
- List the treatment options related to the care of a patient experiencing GVHD.
Additional Information
The Norman Knight Nursing Center
Please visit our website at https://www.mghpcs.org/KNCPD/default.shtml
Presenter
Zachariah DeFilipp, MD
Nurse Planner
Patricia Crispi PhD(c), RN, NPD-BC
Content Expert
Giuliana De Marchi, NP
Planning Committee
Maria Alfonso, RN
Colleen Walsh, RN
Mass General Brigham designates this activity for 1.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.